Markets have hinted at a sector rotation out of high-momentum stocks. High-flyers such as Tesla, Nvidia, and Square have been among the top investments over the past year. Eric Marshall, President and Director of Research for Hodges Capital Management stopped by Cheddar to discuss whether tech stocks can continue their run higher into 2018.
Marshall says he is encouraged by indications that there may be a shift to more value-oriented segments of the market. His firm is particularly optimistic for consumer-related names and transports. Marshall sees a rotation out of momentum stocks as healthy for markets, which he says keeps equity valuations in check.
Marshall also spots a turnaround for American Eagle. He says his firm likes retail at these levels because they are under-owned. Marshall adds that some retail stocks have been "thrown out with the bathwater," and thinks the adoption of e-commerce and the shutting down of stores could revive the company.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
